Alain Kuyumjian
Lawyers
Filters
Biodesix $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Itaú Corpbanca $1 billion rights offering
The offering included rights to subscribe for new shares and ADSs
Government of Belize debt restructuring
Belize completed settlement of its cash tender offer and consent solicitation for its U.S. dollar bonds due 2034
Sociedad Química y Minera de Chile $700 million green bonds
The investment-grade offering involved 3.5% notes due 2051
Entel $800 million senior notes offering and concurrent tender offer
We advised the initial purchasers on the investment-grade debt and concurrent tender offer
ATAI Life Sciences $258.8 million IPO
We advised the underwriters on the IPO and Nasdaq listing
CMPC $500 million sustainability-linked notes offering
We advised the initial purchasers on the sustainability-linked notes
FTAC Hera Acquisition $800 million IPO
We advised the underwriters on the SPAC IPO and Nasdaq listing
Biodesix $72 million IPO
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million initial public offering by Biodesix, Inc. The common stock is listed on…
CureVac $245.3 million IPO
Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which includes 1,999,999 common shares from the full exercise of the…